Clinical Trial Update: Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a combination of pegylated interferon, ribavirin, and metformin for chronic hepatitis C infection with insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Insulin Resistance

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• metformin (metformin)

Snippet

Sponsor: University of Turin, Italy | Conditions: Chronic Hepatitis C, Insulin Resistance | Phase 4 | Status: UNKNOWN